缺血性脑卒中全基因组关联研究提示阳性基因位点与睡眠行为的交互作用

doi:10.19723/j.issn.1671-167X.2022.03.004

摘要/Abstract

摘要：

目的: 探讨睡眠行为(睡眠时长、睡眠效率、入睡时间)和全基因组关联研究(genome-wide association studies, GWAS)提示阳性缺血性脑卒中(ischemic stroke, IS)基因位点与IS风险的关联，以及睡眠-基因交互作用与IS风险的关联。方法: 基于北京市房山家系队列，在基线对所有研究对象进行问卷调查、体格检查、血生化检测和基因型检测。采用多因素广义线性模型分析睡眠、基因与IS的关联。结果: 共纳入研究对象4 648人，平均年龄(58.5±8.7)岁，其中IS患者有1 316人。相比于非患者，IS患者睡眠时长≥9 h、睡眠效率 < 80%及入睡时间早于22:00占比更高(P均 < 0.05)。多因素广义线性模型下，未见睡眠时长与IS风险的线性关联(OR=1.04，95%CI：0.99~1.10，P=0.085)。睡眠效率与IS风险呈线性负相关(OR=0.18，95%CI：0.06~0.53，P=0.002)；相比于睡眠效率≥80%，睡眠效率 < 80%的IS风险为其1.47倍(95%CI：1.03~2.10，P=0.033)。相较于在22:00—22:59入睡，入睡时间早于22:00的IS风险是其1.26倍(95%CI：1.04~1.52，P=0.017)。多因素模型发现ABO基因上rs579459位点与入睡时间存在交互作用(P_交互=0.040)，rs579459致病等位基因T个数为2时，相比于入睡时间22:00—22:59，早于22:00入睡者IS风险显著升高，为其1.56倍(95%CI：1.20~2.04，P=0.001)，而致病等位基因个数为0或1时无显著关联。仅调整性别、年龄、家系的模型中，睡眠时长与PITX2基因上rs2634074致病等位基因T的个数对IS存在交互作用(P_交互=0.033)。结论: 睡眠效率降低与IS风险增高有关，入睡时间早于22:00与较高的IS风险相关。入睡时间与ABO基因上rs579459和IS风险存在交互作用；睡眠时长与PITX2基因上rs2634074和IS风险可能存在潜在的交互作用。

关键词: 基因位点, 睡眠, 缺血性脑卒中, 交互作用

Abstract:

Objective: To explore the relationship between sleep habits (sleep duration, sleep efficiency, sleep onset timing) and ischemic stroke, and whether there is an interaction between sleep habits and ischemic stroke susceptibility gene loci. Methods: A questionnaire survey, physical examination, blood biochemical testing and genotyping were conducted among rural residents in Beijing, and the gene loci of ischemic stroke suggested by previous genome-wide association studies (GWAS) were screened. Multivariable generalized linear model was used to analyze the correlation between sleep habits, sleep-gene interaction and ischemic stroke. Results: A total of 4 648 subjects with an average age of (58.5±8.7) years were enrolled, including 1 316 patients with ischemic stroke. Compared with non-stroke patients, stroke patients with sleep duration ≥9 hours, sleep efficiency < 80%, and sleep onset timing earlier than 22:00 accounted for a higher proportion (P < 0.05). There was no significant association between sleep duration and risk of ischemic stroke (OR=1.04, 95%CI: 0.99-1.10, P=0.085). Sleep efficiency was inversely associated with the risk of ischemic stroke (OR=0.18, 95%CI: 0.06-0.53, P=0.002). The risk of ischemic stroke in the subjects with sleep efficiency < 80% was 1.47-fold (95%CI: 1.03-2.10, P=0.033) of that in the subjects with sleep efficiency ≥80%. Falling asleep earlier than 22:00 was associated with 1.26 times greater risk of stroke than falling asleep between 22:00 and 22:59 (95%CI: 1.04-1.52, P=0.017). Multifactorial adjustment model showed that rs579459 on ABO gene had an interaction with sleep time (P for interaction =0.040). When there were two T alleles for rs579459 on the ABO gene, those who fell asleep before 22:00 had 1.56 times (95%CI: 1.20-2.04, P=0.001) the risk of stroke compared with those who fell asleep between 22:00 and 22:59, and there was no significant difference when the number of pathogenic alleles was 0 or 1. In the model adjusted only for gender, age and family structure, sleep duration and the number of T allele rs2634074 on PITX2 gene had an interaction with ischemic stroke (P for interaction=0.033). Conclusion: Decreased sleep efficiency is associated with increased risk of ischemic stroke, and falling asleep earlier than 22:00 is associated with higher risk of ischemic stroke. Sleep onset timing interacted with rs579459 in ABO gene and the risk of ischemic stroke. Sleep duration and PITX2 rs2634074 may have a potential interaction with ischemic stroke risk.

Key words: Gene loci, Sleep, Ischemic stroke, Interaction

中图分类号:

R181

杨若彤,王梦莹,李春男,于欢,王小文,吴俊慧,王斯悦,王伽婷,陈大方,吴涛,胡永华. 缺血性脑卒中全基因组关联研究提示阳性基因位点与睡眠行为的交互作用[J]. 北京大学学报（医学版）, 2022, 54(3): 412-420.

Ruo-tong YANG,Meng-ying WANG,Chun-nan LI,Huan YU,Xiao-wen WANG,Jun-hui WU,Si-yue WANG,Jia-ting WANG,Da-fang CHEN,Tao WU,Yong-hua HU. Interaction between ischemic stroke risk loci identified by genome-wide association studies and sleep habits[J]. Journal of Peking University (Health Sciences), 2022, 54(3): 412-420.

图/表 5

表1

研究对象基本特征"

Items	Total (n= 4 648)	Participants without IS (n= 3 332)	Participants with IS (n= 1 316)	P
Age/years, $\bar x \pm s$	58.5±8.7	57.5±8.7	60.8±8.3	< 0.001
Male, n (%)	2 112 (45.4)	1 384 (41.5)	728 (55.3)	< 0.001
Married, n (%)	4 060 (87.4)	2 934 (88.0)	1 126 (85.6)	< 0.001
Junior high school education or above, n (%)	2 574 (55.4)	1 962 (58.9)	612 (46.5)	< 0.001
Annual household income /10 000 yuan, $\bar x \pm s$	3.0±4.4	3.2±4.5	2.5±4.2	< 0.001
Smoker, n (%)	1 303 (28.0)	910 (27.3)	393 (29.9)	< 0.001
Drinker, n (%)	1 307 (28.1)	971 (29.1)	336 (25.5)	< 0.001
Adequate exercise, n (%)	892 (19.2)	673 (20.2)	219 (16.6)	0.006
Vegetables≥300 g/d and fruits≥200 g/d, n (%)	2 988 (64.3)	2 149 (64.5)	839 (63.8)	0.634
BMI/(kg/m²), $\bar x \pm s$	26.2±3.5	26.1±3.6	26.3±3.4	0.126
Total cholesterol/(mmol/L), $\bar x \pm s$	3.0±1.1	3.1±1.1	2.9±1.1	0.001
Hypertension, n (%)	3 328 (71.6)	2 182 (65.5)	1 146 (87.1)	< 0.001
Diabetes, n (%)	2 449 (52.7)	1 826 (54.8)	623 (47.4)	< 0.001
Coronary heart disease, n (%)	1 034 (22.3)	668 (20.1)	366 (27.8)	< 0.001
Family medical history, n (%)
IS	2 887 (62.1)	1 769 (53.1)	1 118 (85.0)	< 0.001
Diabetes	3 696 (79.5)	2 838 (85.2)	858 (65.2)	< 0.001
Coronary heart disease	2 299 (49.5)	1 743 (52.3)	556 (42.3)	< 0.001
Sleep duration/h, n (%)				< 0.001
< 7	1 031 (22.2)	758 (22.8)	273 (20.7)
7.0-8.9	2 393 (51.5)	1 768 (53.1)	625 (47.5)
≥9	1 224 (26.3)	806 (24.2)	418 (31.8)
Sleep efficiency/%, n (%)				0.015
≥80	4 378 (94.2)	3 156 (94.7)	1 222 (92.9)
< 80	270 (5.8)	176 (5.3)	94 (7.1)
Sleep onset timing, n (%)				< 0.001
< 22:00	1 111 (23.9)	688 (20.7)	423 (32.1)
22:00-22:59	1 844 (39.7)	1 354 (40.6)	490 (37.2)
23:00-23:59	1 058 (22.8)	822 (24.7)	236 (17.9)
≥24:00	635 (13.7)	468 (14.1)	167 (12.7)

表1

表2

表3

表4

表5

参考文献 45

1	Li W , Wang D , Cao S , et al. Sleep duration and risk of stroke events and stroke mortality: A systematic review and meta-analysis of prospective cohort studies[J]. Int J Cardiol, 2016, 223, 870- 876. doi: 10.1016/j.ijcard.2016.08.302
2	Titova OE , Michaëlsson K , Larsson SC . Sleep duration and stroke: Prospective cohort study and mendelian randomization analysis[J]. Stroke, 2020, 51 (11): 3279- 3285. doi: 10.1161/STROKEAHA.120.029902
3	Zhou L , Yu K , Yang L , et al. Sleep duration, midday napping, and sleep quality and incident stroke: The Dongfeng-Tongji cohort[J]. Neurology, 2020, 94 (4): e345- e356. doi: 10.1212/WNL.0000000000008739
4	Song Q , Liu X , Zhou W , et al. Long sleep duration and risk of ischemic stroke and hemorrhagic stroke: the Kailuan prospective study[J]. Sci Rep, 2016, 6, 33664. doi: 10.1038/srep33664
5	Reed DL , Sacco WP . Measuring sleep efficiency: What should the denominator be[J]. J Clin Sleep Med, 2016, 12 (2): 263- 266. doi: 10.5664/jcsm.5498
6	Didikoglu A , Maharani A , Tampubolon G , et al. Longitudinal sleep efficiency in the elderly and its association with health[J]. J Sleep Res, 2020, 29 (3): e12898.
7	Hirata T , Nakamura T , Kogure M , et al. Reduced sleep efficiency, measured using an objective device, was related to an increased prevalence of home hypertension in Japanese adults[J]. Hypertens Res, 2020, 43 (1): 23- 29. doi: 10.1038/s41440-019-0329-0
8	Yan B , Yang J , Zhao B , et al. Objective sleep efficiency predicts cardiovascular disease in a community population: The sleep heart health study[J]. J Am Heart Assoc, 2021, 10 (7): e016201. doi: 10.1161/JAHA.120.016201
9	Portaluppi F , Tiseo R , Smolensky MH , et al. Circadian rhythms and cardiovascular health[J]. Sleep Med Rev, 2012, 16 (2): 151- 166. doi: 10.1016/j.smrv.2011.04.003
10	Shahram N , Reed AB , Dillon OB , et al. Accelerometer-derived sleep onset timing and cardiovascular disease incidence: A UK Biobank cohort study[J]. Eur Heart J Digital Health, 2021, (4): 4.
11	Korostovtseva L . Ischemic stroke and sleep: The linking genetic factors[J]. Cardiol Ther, 2021, 10 (2): 349- 375. doi: 10.1007/s40119-021-00231-9
12	Fan M , Sun D , Zhou T , et al. Sleep patterns, genetic suscepti-bility, and incident cardiovascular disease: A prospective study of 385 292 UK BioBank participants[J]. Eur Heart J, 2020, 41 (11): 1182- 1189. doi: 10.1093/eurheartj/ehz849
13	王梦莹, 唐迅, 秦雪英, 等. 北方农村地区居民常见慢性非传染性疾病的家系队列研究进展[J]. 中华流行病学杂志, 2018, 39 (1): 94- 97. doi: 10.3760/cma.j.issn.0254-6450.2018.01.020
14	孙可欣, 刘志科, 曹亚英, 等. 北京某社区2型糖尿病患者血糖控制情况与肱踝脉搏波传导速度的相关性研究[J]. 北京大学学报(医学版), 2015, 47 (3): 431- 436. doi: 10.3969/j.issn.1671-167X.2015.03.012
15	Ohayon M , Wickwire EM , Hirshkowitz M , et al. National Sleep Foundation's sleep quality recommendations: first report[J]. Sleep Health, 2017, 3 (1): 6- 19. doi: 10.1016/j.sleh.2016.11.006
16	Cheng YC , Stanne TM , Giese AK , et al. Genome-wide association analysis of young-onset stroke identifies a locus on chromosome 10q25 near HABP2[J]. Stroke, 2016, 47 (2): 307- 316. doi: 10.1161/STROKEAHA.115.011328
17	Malik R , Chauhan G , Traylor M , et al. Multiancestry genome-wide association study of 520 000 subjects identifies 32 loci associated with stroke and stroke subtypes[J]. Nat Genet, 2018, 50 (4): 524- 537. doi: 10.1038/s41588-018-0058-3
18	Gretarsdottir S , Thorleifsson G , Manolescu A , et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke[J]. Ann Neurol, 2008, 64 (4): 402- 409. doi: 10.1002/ana.21480
19	Neurology working group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium , the stroke genetics network (SiGN) , the International Stroke Genetics Consortium (ISGC) . Identification of additional risk loci for stroke and small vessel disease: A meta-analysis of genome-wide association studies[J]. Lancet Neurol, 2016, 15 (7): 695- 707. doi: 10.1016/S1474-4422(16)00102-2
20	Matarín M , Brown WM , Scholz S , et al. A genome-wide genotyping study in patients with ischaemic stroke: Initial analysis and data release[J]. Lancet Neurol, 2007, 6 (5): 414- 420. doi: 10.1016/S1474-4422(07)70081-9
21	Traylor M , Farrall M , Holliday EG , et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): A meta-analysis of genome-wide association studies[J]. Lancet Neurol, 2012, 11 (11): 951- 962. doi: 10.1016/S1474-4422(12)70234-X
22	Dichgans M , Malik R , König IR , et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: A genome-wide analysis of common variants[J]. Stroke, 2014, 45 (1): 24- 36. doi: 10.1161/STROKEAHA.113.002707
23	Smith JG , Melander O , Lövkvist H , et al. Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: A large-scale genetic association study[J]. Circ Cardiovasc Genet, 2009, 2 (2): 159- 164. doi: 10.1161/CIRCGENETICS.108.835173
24	Traylor M , Mäkelä KM , Kilarski LL , et al. A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach[J]. PLoS Genet, 2014, 10 (7): e1004469. doi: 10.1371/journal.pgen.1004469
25	Holliday EG , Maguire JM , Evans TJ , et al. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke[J]. Nat Genet, 2012, 44 (10): 1147- 1151. doi: 10.1038/ng.2397
26	Zhu R , Liu X , He Z , et al. miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population[J]. Neurochem Res, 2014, 39 (9): 1709- 1716. doi: 10.1007/s11064-014-1364-5
27	Wan XH , Li SJ , Cheng P , et al. NINJ2 polymorphism is asso-ciated with ischemic stroke in Chinese Han population[J]. J Neurol Sci, 2011, 308 (1/2): 67- 71.
28	Liu ME , Liao YC , Lin RT , et al. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis[J]. Atherosclerosis, 2013, 228 (1): 161- 167. doi: 10.1016/j.atherosclerosis.2013.01.036
29	Ding H , Xu Y , Bao X , et al. Confirmation of genomewide association signals in Chinese Han population reveals risk loci for ischemic stroke[J]. Stroke, 2010, 41 (1): 177- 180. doi: 10.1161/STROKEAHA.109.567099
30	Domingues-Montanari S , Fernández-Cadenas I , Del Río-Espinola A , et al. KCNK17 genetic variants in ischemic stroke[J]. Atherosclerosis, 2010, 208 (1): 203- 209. doi: 10.1016/j.atherosclerosis.2009.07.023
31	Zhu Y , Liu K , Tang X , et al. Association between NINJ2 gene polymorphisms and ischemic stroke: A family-based case-control study[J]. J Thromb Thrombolysis, 2014, 38 (4): 470- 476. doi: 10.1007/s11239-014-1065-6
32	Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study[J]. Lancet Neurol, 2016, 15(2): 174-184.
33	Ikram MA , Seshadri S , Bis JC , et al. Genomewide association studies of stroke[J]. N Engl J Med, 2009, 360 (17): 1718- 1728. doi: 10.1056/NEJMoa0900094
34	Zhang Y , Tong Y , Zhang Y , et al. Two novel susceptibility SNPs for ischemic stroke using exome sequencing in Chinese Han population[J]. Mol Neurobiol, 2014, 49 (2): 852- 862. doi: 10.1007/s12035-013-8561-0
35	Grandner MA , Buxton OM , Jackson N , et al. Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group[J]. Sleep, 2013, 36 (5): 769- 779e. doi: 10.5665/sleep.2646
36	Ramos AR , Jin Z , Rundek T , et al. Relation between long sleep and left ventricular mass (from a multiethnic elderly cohort)[J]. Am J Cardiol, 2013, 112 (4): 599- 603. doi: 10.1016/j.amjcard.2013.04.029
37	Abe T , Aoki T , Yata S , et al. Sleep duration is significantly associated with carotid artery atherosclerosis incidence in a Japanese population[J]. Atherosclerosis, 2011, 217 (2): 509- 513. doi: 10.1016/j.atherosclerosis.2011.02.029
38	Doyle CY , Ruiz JM , Taylor DJ , et al. Associations between objective sleep and ambulatory blood pressure in a community sample[J]. Psychosom Med, 2019, 81 (6): 545- 556. doi: 10.1097/PSY.0000000000000711
39	Lao XQ , Liu X , Deng HB , et al. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60 586 adults[J]. J Clin Sleep Med, 2018, 14 (1): 109- 117. doi: 10.5664/jcsm.6894
40	Massar SAA , Liu JCJ , Mohammad NB , et al. Poor habitual sleep efficiency is associated with increased cardiovascular and cortisol stress reactivity in men[J]. Psychoneuroendocrinology, 2017, 81, 151- 156. doi: 10.1016/j.psyneuen.2017.04.013
41	Yang L , Chu Y , Wang L , et al. Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-κB pathway[J]. Int Immunopharmacol, 2015, 28 (1): 525- 530. doi: 10.1016/j.intimp.2015.07.001
42	Roenneberg T , Kuehnle T , Juda M , et al. Epidemiology of the human circadian clock[J]. Sleep Med Rev, 2007, 11 (6): 429- 438. doi: 10.1016/j.smrv.2007.07.005
43	Kirchhof P , Kahr PC , Kaese S , et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression[J]. Circ Cardiovasc Genet, 2011, 4 (2): 123- 133. doi: 10.1161/CIRCGENETICS.110.958058
44	Li H , Cai Y , Xu AD . Association study of polymorphisms in the ABO gene and their gene-gene interactions with ischemic stroke in Chinese population[J]. J Clin Lab Anal, 2018, 32 (4): e22329. doi: 10.1002/jcla.22329
45	Sandford AJ , Ha A , Ngan DA , et al. Adhesion molecule gene variants and plasma protein levels in patients with suspected obstructive sleep apnea[J]. PLoS One, 2019, 14 (1): e0210732. doi: 10.1371/journal.pone.0210732

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Sleep behaviors	Model 1		Model 2
Sleep behaviors	OR (95%CI)	P	OR (95%CI)	P
Sleep duration/h	1.04 (0.99, 1.08)	0.115	1.04 (0.99, 1.10)	0.085
< 7	1.04 (0.90, 1.29)	0.407	1.01 (0.83, 1.24)	0.895
7.0-8.9	1.00		1.00
≥9	1.22 (1.04, 1.43)	0.016	1.17 (0.98, 1.40)	0.081
Sleep efficiency/%	0.10 (0.04, 0.26)	< 0.001	0.18 (0.06, 0.53)	0.002
≥80	1.00		1.00
< 80	1.71 (1.25, 2.34)	0.001	1.47 (1.03, 2.10)	0.033
Sleep onset timing
< 22:00	1.44 (1.22, 1.71)	< 0.001	1.26 (1.04, 1.52)	0.017
22:00-22:59	1.00			1.00
23:00-23:59	0.86 (0.72, 1.04)	0.118	0.93 (0.76, 1.15)	0.517
≥24:00	0.86 (0.67, 1.10)	0.223	0.86 (0.66, 1.13)	0.291

Chromosome	rsID	Gene	n	MAF	Risk allele	OR (95%CI)	P	P′
1	rs225132	ERRFI1	4 448	0.34	T	1.09 (0.99, 1.21)	0.083	1.000
1	rs10489177	C1orf156	4 421	0.32	G	1.27 (1.15, 1.41)	< 0.001^*	< 0.001^*
2	rs780094	GCKR	3 440	0.47	G	1.03 (0.92, 1.14)	0.629	1.000
2	rs2292832	miR-149	3 394	0.32	T	1.04 (0.93, 1.17)	0.462	1.000
3	rs16851055	SPSB4	4 380	0.20	G	1.16 (1.03, 1.31)	0.015^*	0.405
4	rs2200733	PITX2	3 345	0.48	T	1.03 (0.93, 1.15)	0.534	1.000
4	rs2634074	PITX2	4 199	0.40	T	1.23 (1.12, 1.36)	< 0.001^*	< 0.001^*
5	rs1428155	GLRA1	3 405	0.32	C	1.03 (0.92, 1.15)	0.597	1.000
5	rs2910164	miR-146a	4 402	0.47	G	0.97 (0.88, 1.07)	0.557	1.000
6	rs556621	HCG27	3 377	0.50	A	1.07 (0.97, 1.19)	0.178	1.000
7	rs662	PON1	3 400	0.37	A	1.12 (1.00, 1.25)	0.042^*	1.000
7	rs3735590	PON1	3 444	0.14	C	1.11 (0.96, 1.30)	0.169	1.000
9	rs579459	ABO	4 418	0.34	T	1.29 (1.17, 1.42)	< 0.001^*	< 0.001^*
9	rs2383207	CDKN2B-AS1	3 438	0.33	A	1.03 (0.92, 1.15)	0.590	1.000
9	rs505922	ABO	4 419	0.48	C	0.96 (0.88, 1.06)	0.446	1.000
10	rs11196288	HABP2	4 391	0.36	G	1.03 (0.93, 1.14)	0.593	1.000
11	rs660599	MMP-12	3 438	0.12	T	0.95 (0.81, 1.11)	0.518	1.000
12	rs12425791	NINJ2	4 409	0.25	A	0.99 (0.89, 1.11)	0.868	1.000
12	rs11614913	MIR-196A2	4 328	0.50	C	0.98 (0.89, 1.08)	0.702	1.000
12	rs10849373	NINJ2	4 423	0.14	G	1.51 (1.28, 1.79)	< 0.001^*	< 0.001^*
12	rs11833579	NINJ2	4 378	0.34	A	1.06 (0.95, 1.17)	0.301	1.000
14	rs1952706	PTCSC3	3 867	0.49	C	0.97 (0.87, 1.07)	0.496	1.000
14	rs2787417	PTCSC3	4 362	0.49	T	0.95 (0.86, 1.04)	0.280	1.000
14	rs934075	PTCSC3	4 415	0.49	G	0.97 (0.88, 1.06)	0.481	1.000
16	rs12445022	JPH3	4 441	0.10	A	1.06 (0.91, 1.23)	0.457	1.000
16	rs879324	ZFHX3	3 433	0.34	T	1.08 (0.97, 1.20)	0.177	1.000
16	rs7193343	ZFHX3	4 428	0.41	T	1.14 (1.03, 1.26)	0.008^*	0.216

rs579459 number of pathogenic alleles	Model 1				Model 2
rs579459 number of pathogenic alleles	0(n=784)	1(n=435)	2(n=201)	P_int	0(n=784)	1(n=1435)	2(n=2201)	P_int
Sleep duration/ h	1.11 (0.97, 1.27)	1.04 (0.96, 1.12)	1.02(0.96, 1.08)	0.889	1.15(0.99, 1.34)	1.03(0.94, 1.13)	1.03 (0.96, 1.11)	0.668
< 7	0.82 (0.47, 1.37)	1.12 (0.81, 1.55)	1.15(0.89, 1. 48)		0.65 (0.35, 1.18)	1.07(0.74, 1.53)	1.14(0.86, 1.51)
7.0 ~8.9	1.00	1.00	1.00		1.00	1.00	1.00
≥9	1.72 (1.08, 2.72)	1.29 (0.96, 1.72)	1.06(0.84, 1.33)		1.97 (1.15, 3.39)	1.15(0.83, 1.61))	1.10 (0.85, 1.42)
Sleep efficiency/%	0.57 (0.07, 5.72)	0.04 (0.01, 0.23)	0.06 (0.01, 0.26)	0.576	0.87(0.07, 13.53)	0.06（0.01, 0.38)	0.16 (0.03, 0.86)	0.661
≥80	1.00	1.00	1.00		1.00	1.00	1.00
< 80	0.70(0.26, 1.74)	2.32 (1.35, 4.02)	1.55(0.97, 2.46)		0.62(0.21, 1.74)	1.85 (1.00, 3.43)	1.27 (0.75, 2.15)
Sleep onset timing
< 22:00	0.78 (0.47, 1.28)	1.21(0.89, 1.66)	1.83 (1.44, 2.32)	0.007	0.65 (0.35, 1.17)	1.02 (0.72, 1.45)	1.56(1.20, 2.04)0.040	0.040
22:00 -22:59	1.00	1.00	1.00		1.00	1.00	1.00
23:00 -23:59	0.84 (0.50, 1.40)	0.91 (0.65, 1.27)	0.85 (0.65, 1.10)	0.782	0.70 (0.38, 1.25)	1.00 (0.69, 1.44)	0.97 (0.72, 1.29)	0.310
≥24：00	1.63 (0.83, 3.10)	0.72 (0.45, 1.11)	0.84 (0.59, 1.19)	0.719	1.45 (0.67, 3.07)	0.72 (0.44, 1.17)	0.88 (0.59, 1.29)	0.954

rs2634074 number of pathogenic alleles	Model 1				Model 2
rs2634074 number of pathogenic alleles	0(n=935)	1(n=1469)	2(n=1795)	P_int	0(n=935)	1(n=1469)	2(n=1795)	P_int
Sleep duration /h	1.14 (1.02, 1.28)	1.08 (0.99, 1.17)	0.97 (0.90, 1.03)	0.033	1.15 (1.02, 1.31)	1.09 (0.99, 1.20)	0.97 (0.90, 1.05)	0.060
< 7	0.74 (0.45, 1.20)	1.01 (0.72, 1.42)	1.18 (0.90, 1.55)		0.73 (0.43, 1.24)	0.94 (0.64, 1.37)	1.11 (0.82, 1.50)
7.0 -8.9	1.00	1.00	1.00		1.00	1.00	1.00
≥9	1.66 (1.12, 2.45)	1.19 (0.89, 1.60)	1.01 (0.79, 1.30)		1.71 (1.10, 2.65)	1.18 (0.85, 1.64)	1.00 (0.75, 1.33)
Sleep efficiency /%	0.08 (0.01, 0.73)	0.24 (0.05, 1.27)	0.04 (0.01, 0.24)	0.532	0.14 (0.01, 1.58)	0.61 (0.09, 4.49)	0.03 (0.00, 0.23)	0.230
≥80	1.00	1.00	1.00		1.00	1.00	1.00
< 80	1.62 (0.71, 3.62)	1.58 (0.90, 2.74)	1.76 (1.04, 2.96)		1.35 (0.54, 3.32)	1.22 (0.64, 2.29)	1.84 (1.02, 3.33)
Sleep onsettiming
< 22:00	1.00 (0.65, 1.54)	1.58 (1.16, 2.17)	1.52 (1.17, 1.98)	0.606	0.80 (0.49, 1.29)	1.22 (0.85, 1.74)	1.45 (1.08, 1.94)	0.223
22:00 -22:59	1.00	1.00	1.00		1.00	1.00	1.00
23:00 -23:59	1.13 (0.71, 1.77)	0.86 (0.62, 1.20)	0.78 (0.58, 1.05)	0.398	1.30 (0.78, 2.14)	0.85 (0.58, 1.22)	0.88 (0.64, 1.22)	0.505
≥24：00	0.99 (0.52, 1.81)	1.01 (0.66, 1.54)	0.76 (0.50, 1.13)	0.785	0.86 (0.42, 1.70)	0.93 (0.58, 1.49)	0.83 (0.53, 1.29)	0.625

[1]	马雨佳,卢燃藜,周泽宸,李晓怡,闫泽玉,武轶群,陈大方. 基于两样本孟德尔随机化的失眠与2型糖尿病关联研究[J]. 北京大学学报（医学版）, 2024, 56(1): 174-178.
[2]	于欢,杨若彤,王斯悦,吴俊慧,王梦莹,秦雪英,吴涛,陈大方,武轶群,胡永华. 2型糖尿病患者使用二甲双胍与缺血性脑卒中发病风险的队列研究[J]. 北京大学学报（医学版）, 2023, 55(3): 456-464.
[3]	邓佳慧,黄筱琳,刘晓星,孙杰,陆林. 中国睡眠医学的过去、现在和未来[J]. 北京大学学报（医学版）, 2023, 55(3): 567-封三.
[4]	陈曦,王斯悦,薛恩慈,王雪珩,彭和香,范梦,王梦莹,武轶群,秦雪英,李劲,吴涛,朱洪平,李静,周治波,陈大方,胡永华. 基于核心家系全外显子组测序数据探索新生突变与非综合征型唇腭裂的关联[J]. 北京大学学报（医学版）, 2022, 54(3): 387-393.
[5]	朱小玲,李文静,王宪娥,宋文莉,徐莉,张立,冯向辉,路瑞芳,释栋,孟焕新. 细胞色素B-245α链及胆固醇酯转运蛋白基因多态性与广泛型侵袭性牙周炎易感性的关系[J]. 北京大学学报（医学版）, 2022, 54(1): 18-22.
[6]	霍阳,周兵,何红彦,赵龙,张雪丽,李静,左玉花,郑宇,任正洪,韩芳,张俊. 腕表式睡眠监测仪与多导睡眠监测的睡眠参数比较和相关性分析[J]. 北京大学学报（医学版）, 2021, 53(5): 942-945.
[7]	张绍兴,姚子明,栾胜,王丽,徐颖. 使用多参数压敏式便携睡眠监测系统检测阻塞型睡眠呼吸暂停伴低通气综合征[J]. 北京大学学报（医学版）, 2021, 53(3): 608-612.
[8]	王一帆,范稹,成姚斌,金月波,霍阳,何菁. 原发性干燥综合征患者睡眠障碍的相关影响因素[J]. 北京大学学报（医学版）, 2020, 52(6): 1063-1068.
[9]	董冰婉,张俊波,肖水芳. Friedman分型联合术后早期睡眠脉氧监测对悬雍垂腭咽成形术疗效的预测价值[J]. 北京大学学报（医学版）, 2020, 52(2): 281-284.
[10]	包海荣,刘晓菊,谭恩丽,舒娟,董继元,李盛. 兰州市气温和相对湿度对慢性阻塞性肺疾病患者门诊就诊人次的影响及其交互效应[J]. 北京大学学报（医学版）, 2020, 52(2): 308-316.
[11]	谢江,李菲. 睡眠重叠综合征与糖尿病发病率的横断面调查研究[J]. 北京大学学报（医学版）, 2019, 51(2): 252-255.
[12]	贾子昌,李选,李小刚,曾祥柱,栾景源,王昌明,韩金涛. 机械取栓治疗急性缺血性脑卒中单中心研究[J]. 北京大学学报（医学版）, 2019, 51(2): 256-259.
[13]	陈天麒，董彬，张文静，高迪思，董彦会，马军，马迎华. 儿童青少年睡眠时间与速度和耐力成绩的相关性研究[J]. 北京大学学报(医学版), 2018, 50(3): 429-435.
[14]	龚潘，杨志仙，薛姣，钱萍，杨海坡，刘晓燕，边凯归. 头皮脑电图中高频振荡在癫痫性脑病伴睡眠中持续棘慢波患儿中的应用[J]. 北京大学学报(医学版), 2018, 50(2): 213-220.
[15]	马运东, 黄东, 陈宇峰, 姜皓云, 刘军华, 孙洪强, 李志宏. 应用于无线多导睡眠监测的皮肤贴电极制备及验证[J]. 北京大学学报(医学版), 2018, 50(2): 358-363.